AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Pritchard, KI
Citation: Ki. Pritchard, Optimal endocrine therapy, BREAST, 10, 2001, pp. 114-122

Authors: Sawka, CA Pritchard, KI
Citation: Ca. Sawka et Ki. Pritchard, Can improved communication increase patient participation in randomised clinical trials?, EUR J CANC, 37(3), 2001, pp. 297-299

Authors: Pritchard, KI
Citation: Ki. Pritchard, The role of hormone replacement therapy in women with a previous diagnosisof breast cancer and a review of possible alternatives, ANN ONCOL, 12(3), 2001, pp. 301-310

Authors: Pritchard, KI Levine, M Walley, B
Citation: Ki. Pritchard et al., Raloxifene: handle with care, CAN MED A J, 165(2), 2001, pp. 151

Authors: Pritchard, KI
Citation: Ki. Pritchard, Use of ErbB-1 and ErbB-2 to select endocrine therapy for breast cancer: Will it play in Peoria?, J CL ONCOL, 19(18), 2001, pp. 3795-3797

Authors: Bordeleau, L Rakovitch, E Naimark, DM Pritchard, KI Ackerman, I Sawka, GA
Citation: L. Bordeleau et al., A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis, CANCER, 92(1), 2001, pp. 23-29

Authors: Pritchard, KI
Citation: Ki. Pritchard, Tamoxifen for the prevention of breast cancer - Arbiter, EUR J CANC, 36(2), 2000, pp. 148-150

Authors: Pritchard, KI
Citation: Ki. Pritchard, Endocrine therapy for breast cancer, ONCOLOGY-NY, 14(4), 2000, pp. 483-492

Authors: Pritchard, KI
Citation: Ki. Pritchard, Should tamoxifen be used to treat premenopausal women with breast cancer?, CANCER INV, 18(7), 2000, pp. 685-686

Authors: Norris, B Pritchard, KI James, K Myles, J Bennett, K Marlin, S Skillings, J Findlay, B Vandenberg, T Goss, P Latreille, J Rudinskas, L Lofters, W Trudeau, M Osoba, D Rodgers, A
Citation: B. Norris et al., Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8, J CL ONCOL, 18(12), 2000, pp. 2385-2394

Authors: Pritchard, KI
Citation: Ki. Pritchard, Osteoporosis in patients with a history of breast cancer treated with estrogen-replacement therapy, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 515-537

Authors: Goodwin, PJ Pritchard, KI Spiegel, D
Citation: Pj. Goodwin et al., The Fox guarding the clinical trial: Internal vs. external validity in randomized studies, PSYCHO-ONC, 8(3), 1999, pp. 275-275

Authors: Bramwell, VHC Pritchard, KI
Citation: Vhc. Bramwell et Ki. Pritchard, Tamoxifen added to adjuvant chemotherapy in premenopausal women with earlybreast cancer: is it standard practice or still a subject for study?, EUR J CANC, 35(12), 1999, pp. 1625-1627

Authors: Goodwin, PJ Ennis, M Pritchard, KI Trudeau, M Hood, N
Citation: Pj. Goodwin et al., Risk of menopause during the first year after breast cancer diagnosis, J CL ONCOL, 17(8), 1999, pp. 2365-2370

Authors: Goodwin, PJ Ennis, M Pritchard, KI McCready, D Koo, J Sidlofsky, S Trudeau, M Hood, N Redwood, S
Citation: Pj. Goodwin et al., Adjuvant treatment ant onset of menopause predict weight gain after breastcancer diagnosis, J CL ONCOL, 17(1), 1999, pp. 120-129
Risultati: 1-15 |